Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis.

Wang, LiuyangORCID logo; Ko, Emily RORCID logo; Gilchrist, James J; Pittman, Kelly JORCID logo; Rautanen, Anna; Pirinen, Matti; Thompson, J Will; Dubois, Laura G; Langley, Raymond JORCID logo; Jaslow, Sarah LORCID logo; +15 more...Salinas, Raul E; Rouse, D ClayburnORCID logo; Moseley, M ArthurORCID logo; Mwarumba, Salim; Njuguna, Patricia; Mturi, Neema; Wellcome Trust Case Control Consortium 2; Kenyan Bacteraemia Study Group; Williams, Thomas NORCID logo; Scott, J Anthony GORCID logo; Hill, Adrian VS; Woods, Christopher WORCID logo; Ginsburg, Geoffrey S; Tsalik, Ephraim LORCID logo; and Ko, Dennis C (2017) Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis. Science advances, 3 (3). e1602096-. ISSN 2375-2548 DOI: 10.1126/sciadv.1602096
Copy

Sepsis is a deleterious inflammatory response to infection with high mortality. Reliable sepsis biomarkers could improve diagnosis, prognosis, and treatment. Integration of human genetics, patient metabolite and cytokine measurements, and testing in a mouse model demonstrate that the methionine salvage pathway is a regulator of sepsis that can accurately predict prognosis in patients. Pathway-based genome-wide association analysis of nontyphoidal Salmonella bacteremia showed a strong enrichment for single-nucleotide polymorphisms near the components of the methionine salvage pathway. Measurement of the pathway's substrate, methylthioadenosine (MTA), in two cohorts of sepsis patients demonstrated increased plasma MTA in nonsurvivors. Plasma MTA was correlated with levels of inflammatory cytokines, indicating that elevated MTA marks a subset of patients with excessive inflammation. A machine-learning model combining MTA and other variables yielded approximately 80% accuracy (area under the curve) in predicting death. Furthermore, mice infected with Salmonella had prolonged survival when MTA was administered before infection, suggesting that manipulating MTA levels could regulate the severity of the inflammatory response. Our results demonstrate how combining genetic data, biomolecule measurements, and animal models can shape our understanding of disease and lead to new biomarkers for patient stratification and potential therapeutic targeting.


picture_as_pdf
1602096.PMC5342653.pdf
subject
Published Version
Available under Creative Commons: Attribution 3.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads